Jie Hu

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6

Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma

Jian Zhou, Lei Yu, Xue Gao et al. · Journal of Clinical Oncology · 2011 · 637 citations · Full text

Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study

Zheng Wang, Zhenggang Ren, Yi Chen et al. · Clinical Cancer Research · 2018 · 336 citations

Surgical Oncology, Tumor Recurrence, Cancer Management +20

cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity

Zining Wang, Jiemin Chen, Jie Hu et al. · Journal of Clinical Investigation · 2019 · 241 citations · Full text